DL Lew

Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).

Daniel R. Ciocca, S Green, Richard Elledge et al. · PubMed · 1998 · 45 citations

Medicine, Molecular Biology, Oncology +17

Abstract OT1-02-04: SWOG S1418/NRG -BR006: A randomized, phase III trial to evaluate the efficacy and safety of MK-3475 as adjuvant therapy for triple receptor-negative breast cancer with <u>&amp;gt;</u> 1 cm residual invasive cancer or positive lymph nodes (&amp;gt;pN1mic) after neoadjuvant chemotherapy

Lajos Pusztai, WE Barlow, PA Ganz et al. · Cancer Research · 2018 · 24 citations

Medicine, Oncology, Breast Oncology +16

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

JB Smerage, WE Barlow, DF Hayes et al. · Cancer Research · 2013 · 14 citations

Medicine, Oncology, Breast Oncology +14

S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226.

Mehta Rs, WE Barlow, KS Albain et al. · Cancer Research · 2011 · 13 citations

Medicine, Oncology, Pharmacology +16